Giant Cell Arteritis
📧 Sign up to get email alerts when something new happens for Giant Cell Arteritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis [Phase 2]
Phase 2 trial evaluating abatacept for adults with Takayasu arteritis and giant cell arteritis completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study. [Phase 2]
Phase 2 proof-of-concept trial evaluating tocilizumab as add-on therapy to corticosteroids in giant cell arteritis (completed).
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission. [Phase 4]
Phase 4 trial update on dose-tapering and interruption of tocilizumab in Giant Cell Arteritis patients who have achieved clinical remission.
-
CLINICAL_TRIALS withdrawal · 2017-07-12Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA) [Phase 3]
A Phase 3 trial evaluating subcutaneous abatacept with steroid treatment vs steroids alone in adults with Giant Cell Arteritis has been with…
-
FDA approval · 2017-05-22FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for ACTEMRA (tocilizumab) submitted by Genentech, Inc. The supplementary filing status is AP (approv…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA) [Phase 3]
Phase 3 clinical trial evaluating efficacy and safety of tocilizumab (RoActemra/Actemra) in Giant Cell Arteritis has completed with results …
-
CLINICAL_TRIALS research · 2017-04-25Clinical Trial Update: Polymyalgia Rheumatica and Giant Cell Arteritis
Clinical trial update for Polymyalgia Rheumatica and Giant Cell Arteritis; the current status of the study is unknown.
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis
This clinical trial update reports the completion of a study evaluating carotid artery neovascularization in patients with Takayasu's arteri…
-
CLINICAL_TRIALS research · 2016-08-19Clinical Trial Update: American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis
This clinical trial update describes progress on the ACR/EULAR diagnostic and classification criteria for primary systemic vasculitis, spons…
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Impact of Vasculitis on Employment and Income
This completed clinical trial update examines how vasculitis and its subtypes impact employment and income for patients.
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Hydroxychloroquine in Giant Cell Arteritis [Phase 3]
Phase 3 clinical trial evaluating hydroxychloroquine for Giant Cell Arteritis has completed.
-
CLINICAL_TRIALS research · 2015-08-14Clinical Trial Update: Giant Cell Arteritis: Improving Use of Ultrasound Evaluation
Clinical trial update from the University of Oxford about improving the use of ultrasound evaluation in Giant Cell Arteritis.
-
CLINICAL_TRIALS research · 2015-07-17Clinical Trial Update: Temporal Artery Biopsy vs ULtrasound in Diagnosis of GCA (TABUL)
The TABUL trial comparing temporal artery biopsy versus ultrasound for diagnosing giant cell arteritis has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis [Phase 2]
A Phase II randomized study compared glucocorticoids with versus without methotrexate for giant cell arteritis; the trial has completed.
-
FDA approval · 2014-11-13FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for ACTEMRA (tocilizumab) submitted by Genentech, Inc. This action involves an approved product …
-
CLINICAL_TRIALS research · 2014-07-15Clinical Trial Update: Educational Needs of Patients With Systemic Vasculitis
The document reports on a completed clinical trial evaluating the educational needs and resources for patients with systemic vasculitis.
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Vasculitis Illness Perception (VIP) Study
The Vasculitis Illness Perception (VIP) study has completed. The update lists several vasculitis conditions studied, including granulomatosi…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Reproductive Health in Men and Women With Vasculitis
A completed clinical trial evaluating reproductive health in men and women with various forms of vasculitis.
-
CLINICAL_TRIALS research · 2014-04-09Clinical Trial Update: Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis [Phase 4]
Phase 4 clinical trial update examining the pharmacokinetics of steroids and the response to prednisone therapy in Giant Cell Arteritis. The…
-
FDA approval · 2012-08-13FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Actemra (tocilizumab) submitted by Genentech, broadening its labeling.
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis [Phase 3]
Phase 3 trial update evaluating adalimumab (Humira) to spare steroid use in giant cell arteritis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis [Phase 2]
A Phase 2 clinical trial evaluating infliximab (Remicade) for safety and effectiveness in giant cell arteritis has been terminated.
-
CLINICAL_TRIALS research · 2010-05-26Clinical Trial Update: Diagnostic Study of Temporal Arteritis
Clinical trial update describing a diagnostic study of temporal arteritis, also known as giant cell arteritis.
-
CLINICAL_TRIALS trial_result · 2007-04-23Clinical Trial Update: MRI Superficial Temporal Artery [Phase 1]
Phase 1 clinical trial evaluating MRI imaging of the superficial temporal artery for giant cell arteritis; the study conducted by University…
-
CLINICAL_TRIALS trial_result · 2006-12-06Clinical Trial Update: Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal Arteritis [EARLY_Phase 1]
A Phase 1 trial is evaluating the sensitivity and specificity of color Doppler-directed temporal artery biopsy compared with standard random…